Vivimed Labs Ltd
NSE:VIVIMEDLAB
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
|
Vivimed Labs Ltd
NSE:VIVIMEDLAB
|
747.1m INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.4B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Vivimed Labs Ltd
Glance View
Vivimed Labs Ltd. engages in the manufacture and market of active ingredients, which are used in home and personal care products and industrial care products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2005-08-13. The company operates in two segments: Specialty Chemicals Business and Pharma Business. The company serves various companies through the contract manufacturing (CMO) division, which offers a range of products, such as capsules and tablets, syrups and liquids, and nasal sprays and ointments. The active ingredients manufactured by the Company are used in home and personal care segments, such as hair, skin, oral care and anti-microbial preservatives. Its products include DICLOFENAC GEL BP, LULICONAZOLE CREAM, PERMETHRIN LOTION, and CLOTRIMAZOLE VAGINAL GEL. Its subsidiaries include Finoso Pharma Private Limited, Vivimed Specialty Chemicals Private Limited, Vivimed Holdings Limited, and Vivimed Labs USA INC.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Vivimed Labs Ltd is -23.4%, which is above its 3-year median of -86.1%.
Over the last 3 years, Vivimed Labs Ltd’s Net Margin has increased from -40.7% to -23.4%. During this period, it reached a low of -214.7% on Dec 31, 2023 and a high of -16.3% on Dec 31, 2024.
